Ticker

No recent analyst price targets found for NSCIF.

Latest News for NSCIF

Nanalysis Announces Fourth Quarter and Full Year 2025 Results

Reports Quarterly Revenue of $10.7 Million and Adjusted EBITDA of $1.2 Million Full Year Revenue of $40.1 Million and Adjusted EBITDA of $903 Thousand CALGARY, AB, April 8, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR spectrometers and MRI technology for industrial and research applications announces its financial results for the fourth quarter and…

PRNewsWire • Apr 8, 2026
Nanalysis Announces Fourth Quarter and Full Year 2025 Conference Call

Hosting Call at 10am ET on Thursday, April 9th CALGARY, AB, April 2, 2026 /PRNewswire/ - Nanalysis Scientific Corp. ("the Company", TSXV: NSCI, FRA: 1N1), a leader in portable NMR instruments and imaging technology and services for industrial and research applications announces that on Wednesday, April 8th 2026, the Company will put out a press release after the market close and Chief Executive Officer Sean…

PRNewsWire • Apr 2, 2026
Nanalysis Announces Closing of Second Tranche to Complete its $3.4 Million Offering

CALGARY, AB, Jan. 26, 2026 /PRNewswire/ - Nanalysis Scientific Corp. (the "Company" or "Nanalysis") ( TSXV: NSCI , OTCQX: NSCIF , FRA: 1N1 ) is pleased to announce, further to its December 8, 2025 and December 23, 2025 news releases, that it has closed the second and final tranche the ("Second Tranche") of its $3.4 million non-brokered private placement of units (the "Offering"). Under the Second Tranche, the…

PRNewsWire • Jan 26, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for NSCIF.

No Senate trades found for NSCIF.

No House trades found for NSCIF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top